Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor
Table 1
Summary of lab tests on serodeconverted HIV-positive patients treated with V1.
No.
Gender
Age
HIV disease stage as per the WHO criteria
Months since known as being infected as per patient's recollection
First tested positive (m/y)
Months on V1
HIV positive timesa
HIV negative timesb
HIV PCR copies beforec
HIV PCR copies after
Qualitative PCRd positive
Qualitative PCRd negative
01
F
30
4
1
3/00
14
2
5
617
<50
2
02
F
38
2
0.5
7/01
2
2
4
<50
1
03
F
31
3
18
9/01
4
4
8
2
1
04
F
24
4
18
10/01
4
1
1
05
F
27
3
2
9/01
2
4
1
1830
06
M
26
3
Unknown
4/01
1
2
2
<50
07
F
19
3
Unknown
6/01
1
1
3
08
M
28
4
15
6/02
10
1
7
1
09
M
32
3
7
4/00
15
1
10
127; 2710
<400; <50
1
10
F
28
3
7
8/01
3
5
0
1140; 1620
1
1
11
F
29
4
2
11/01
8
7
0
<50; <400
2
2
12
M
24
4
24
5/02
11
3
5
43900
13
M
28
3
12
2/02
9
1
4
14
M
30
4
36
3/02
10
1
3
15
M
40
4
120
3/02
10
1
1
16
M
58
4
6
1/02
6
1
1
17
M
32
2
0.5
12/01
0.5
1
1
18
M
38
4
96
2/02
11
1
3
19
M
43
4
32
5/02
11
1
4
20
M
33
3
Unknown
5/02
3
1
1
21
M
2
4
24
8/02
15
1
2
22
M
2
4
24
3/02
2
1
3
23
F
29
4
Unknown
2/02
13
1
1
<400
aTests were done at baseline before treatment initiation.bTests were performed after treatment initiation.cTests were done after treatment initiation, not at baseline.dDue to high cost, some patients had qualitative PCR tests, that is,
positive or negative, rather than quantitative ones—all of such tests
were carried out after treatment initiation.
